We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $52.8B
1-Year Est. Return 58.98%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+58.98%
3 Year Est. Return
+167.96%
5 Year Est. Return
+202.28%
10 Year Est. Return
+627.19%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$111M
2
SAP icon
SAP
SAP
+$107M
3
BAM icon
Brookfield Asset Management
BAM
+$98.6M
4
BNS icon
Scotiabank
BNS
+$89M
5
CNQ icon
Canadian Natural Resources
CNQ
+$81.7M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLZE icon
601
Backblaze
BLZE
$1.26B
$3.36M 0.01%
696,519
+186,124
+36% +$1.15M
HUYA
602
Huya Inc
HUYA
$538M
$3.29M 0.01%
1,025,897
+267,616
+35% +$965K
GBDC icon
603
Golub Capital BDC
GBDC
$3.48B
$3.26M 0.01%
215,615
+14,934
+7% +$229K
MTRX icon
604
Matrix Service
MTRX
$328M
$3.25M 0.01%
261,856
-15,087
-5% -$202K
APA icon
605
APA Corp
APA
$14B
$3.25M 0.01%
154,522
+111,386
+258% +$2.45M
MGA icon
606
Magna International
MGA
$18.7B
$3.25M 0.01%
95,500
-217,417
-69% -$8.35M
XERS icon
607
Xeris Biopharma Holdings
XERS
$1.52B
$3.24M 0.01%
589,471
+418,139
+244% +$1.69M
ST icon
608
Sensata Technologies
ST
$6.61B
$3.22M 0.01%
132,479
-48,482
-27% -$1.34M
TCBX icon
609
Third Coast Bancshares
TCBX
$766M
$3.15M 0.01%
94,302
+18,227
+24% +$632K
HCAT icon
610
Health Catalyst
HCAT
$132M
$3.15M 0.01%
694,361
+439,599
+173% +$2.33M
OOMA icon
611
Ooma
OOMA
$574M
$3.14M 0.01%
239,992
+10,771
+5% +$153K
ANIP icon
612
ANI Pharmaceuticals
ANIP
$1.72B
$3.13M 0.01%
46,750
+31,308
+203% +$1.87M
IDCC icon
613
InterDigital
IDCC
$8.88B
$3.13M 0.01%
+15,134
New +$3.05M
BTI icon
614
British American Tobacco
BTI
$124B
$3.12M 0.01%
75,424
-651,691
-90% -$25.6M
COLL icon
615
Collegium Pharmaceutical
COLL
$913M
$3.09M 0.01%
+103,359
New +$3.16M
CLOV icon
616
Clover Health Investments
CLOV
$2.38B
$3.08M 0.01%
859,037
-184,506
-18% -$741K
WLFC icon
617
Willis Lease Finance
WLFC
$1.15B
$3.08M 0.01%
58,551
-2,334
-4% -$148K
MGNI icon
618
Magnite
MGNI
$3.53B
$3.07M 0.01%
269,286
-36,750
-12% -$586K
REZI icon
619
Resideo Technologies
REZI
$3.1B
$3.06M 0.01%
172,744
+133,855
+344% +$2.75M
ULCC icon
620
Frontier Group Holdings
ULCC
$1.57B
$3.04M 0.01%
699,495
-226,598
-24% -$1.69M
SSYS icon
621
Stratasys
SSYS
$779M
$3.02M 0.01%
308,344
-31,657
-9% -$325K
ETON icon
622
Eton Pharmaceutcials
ETON
$1.12B
$3.02M 0.01%
232,532
+17,654
+8% +$267K
COF icon
623
Capital One
COF
$137B
$3.02M 0.01%
16,818
+11,340
+207% +$2.14M
KEP icon
624
Korea Electric Power
KEP
$14.8B
$3.01M 0.01%
405,730
-528,487
-57% -$3.9M
KMPR icon
625
Kemper
KMPR
$1.59B
$3M 0.01%
44,942
+19,194
+75% +$1.27M
23 24
25
26 27

Similar funds

Betterment LLC
Betterment LLC New York $52.8B AUM 15.34% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
SCP
Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.